These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8188342)

  • 21. Neutralisation of Cryptosporidium parvum sporozoites by immunoglobulin and non-immunoglobulin components in serum.
    Hill BD; Dawson AM; Blewett DA
    Res Vet Sci; 1993 May; 54(3):356-60. PubMed ID: 8337483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gliding motility leads to active cellular invasion by Cryptosporidium parvum sporozoites.
    Wetzel DM; Schmidt J; Kuhlenschmidt MS; Dubey JP; Sibley LD
    Infect Immun; 2005 Sep; 73(9):5379-87. PubMed ID: 16113253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apical Secretory Glycoprotein Complex Contributes to Cell Attachment and Entry by Cryptosporidium parvum.
    Akey ME; Xu R; Ravindran S; Funkhouser-Jones L; Sibley LD
    mBio; 2023 Feb; 14(1):e0306422. PubMed ID: 36722968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cloning and expression of a cDNA encoding epitopes shared by 15- and 60-kilodalton proteins of Cryptosporidium parvum sporozoites.
    Jenkins MC; Fayer R; Tilley M; Upton SJ
    Infect Immun; 1993 Jun; 61(6):2377-82. PubMed ID: 7684726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteomics analysis and protein expression during sporozoite excystation of Cryptosporidium parvum (Coccidia, Apicomplexa).
    Snelling WJ; Lin Q; Moore JE; Millar BC; Tosini F; Pozio E; Dooley JS; Lowery CJ
    Mol Cell Proteomics; 2007 Feb; 6(2):346-55. PubMed ID: 17124246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NADPH oxidase, MPO, NE, ERK1/2, p38 MAPK and Ca2+ influx are essential for Cryptosporidium parvum-induced NET formation.
    Muñoz-Caro T; Lendner M; Daugschies A; Hermosilla C; Taubert A
    Dev Comp Immunol; 2015 Oct; 52(2):245-54. PubMed ID: 26026247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Receptor/ligand interactions between Cryptosporidium parvum and the surface of the host cell.
    Nesterenko MV; Woods K; Upton SJ
    Biochim Biophys Acta; 1999 Jul; 1454(2):165-73. PubMed ID: 10381561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A chemiluminescence immunoassay for evaluation of Cryptosporidium parvum growth in vitro.
    You X; Arrowood MJ; Lejkowski M; Xie L; Schinazi RF; Mead JR
    FEMS Microbiol Lett; 1996 Mar; 136(3):251-6. PubMed ID: 8867380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A simple and reliable method of producing in vitro infections of Cryptosporidium parvum (Apicomplexa).
    Upton SJ; Tilley M; Nesterenko MV; Brillhart DB
    FEMS Microbiol Lett; 1994 May; 118(1-2):45-9. PubMed ID: 8013881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Host cell fate on Cryptosporidium parvum egress from MDCK cells.
    Elliott DA; Clark DP
    Infect Immun; 2003 Sep; 71(9):5422-6. PubMed ID: 12933897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cryptosporidium parvum attachment to and internalization by human biliary epithelia in vitro: a morphologic study.
    Huang BQ; Chen XM; LaRusso NF
    J Parasitol; 2004 Apr; 90(2):212-21. PubMed ID: 15165040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cryptosporidium parvum: identification of a new surface adhesion protein on sporozoite and oocyst by screening of a phage-display cDNA library.
    Yao L; Yin J; Zhang X; Liu Q; Li J; Chen L; Zhao Y; Gong P; Liu C
    Exp Parasitol; 2007 Apr; 115(4):333-8. PubMed ID: 17097085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microbial adhesion of Cryptosporidium parvum: identification of a colostrum-derived inhibitory lipid.
    Schmidt J; Kuhlenschmidt MS
    Mol Biochem Parasitol; 2008 Nov; 162(1):32-9. PubMed ID: 18675305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of immunoglobulin A monoclonal antibodies against P23 in controlling murine Cryptosporidium parvum infection.
    Enriquez FJ; Riggs MW
    Infect Immun; 1998 Sep; 66(9):4469-73. PubMed ID: 9712802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cryptosporidium parvum merozoites share neutralization-sensitive epitopes with sporozoites.
    Bjorneby JM; Riggs MW; Perryman LE
    J Immunol; 1990 Jul; 145(1):298-304. PubMed ID: 2193057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phospholipases and cationic peptides inhibit Cryptosporidium parvum sporozoite infectivity by parasiticidal and non-parasiticidal mechanisms.
    Carryn S; Schaefer DA; Imboden M; Homan EJ; Bremel RD; Riggs MW
    J Parasitol; 2012 Feb; 98(1):199-204. PubMed ID: 21787211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of an immunogenic glycocalyx on the surfaces of Cryptosporidium parvum oocysts and sporozoites.
    Nanduri J; Williams S; Aji T; Flanigan TP
    Infect Immun; 1999 Apr; 67(4):2022-4. PubMed ID: 10085053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cryptosporidium parvum apical complex glycoprotein CSL contains a sporozoite ligand for intestinal epithelial cells.
    Langer RC; Riggs MW
    Infect Immun; 1999 Oct; 67(10):5282-91. PubMed ID: 10496907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microbial adhesion of Cryptosporidium parvum sporozoites: purification of an inhibitory lipid from bovine mucosa.
    Johnson JK; Schmidt J; Gelberg HB; Kuhlenschmidt MS
    J Parasitol; 2004 Oct; 90(5):980-90. PubMed ID: 15562596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selection and identification of a new adhesion protein of Cryptosporidium parvum from a cDNA library by ribosome display.
    Xiao D; Yin C; Zhang Q; Li JH; Gong PT; Li SH; Zhang GC; Gao YJ; Zhang XC
    Exp Parasitol; 2011 Oct; 129(2):183-9. PubMed ID: 21740903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.